insights_auto
Why is TWST up 5.08%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
$159.78
arrow_upward
+5.08%(+7.73) 1D
$159.74
arrow_downward
-0.03% (-0.040)bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$152.69
High
$168.93
Low
$152.14
Mkt. cap
10.59B
Avg. vol.
2.57M
Volume
3.54M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
Open
$152.69
High
$168.93
Low
$152.14
Mkt. cap
10.59B
Avg. vol.
2.57M
Volume
3.54M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
StocksToTrade
·
38 minutes ago
Twist Bioscience Surges as Lilly AI Deal Fuels Bullish Targets
Stock Titan
·
2 hours ago
A proposed 2,462-share sale at Twist Bioscience (TWST) includes shares to cover an equity-award tax bill.
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp